Homestead Advisers Corp Sells 85,900 Shares of Abbott Laboratories (NYSE:ABT)

Homestead Advisers Corp reduced its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 7.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,015,246 shares of the healthcare product maker’s stock after selling 85,900 shares during the period. Abbott Laboratories accounts for about 2.9% […]

Related Keywords

Canada ,Wellington ,New Zealand General ,New Zealand ,Lisad Earnhardt ,Raymond James ,Roberte Funck ,Goldman Sachs Group ,Royal Bank ,Abbott Laboratories ,Capital International Investors ,Exchange Commission ,Barclays ,Capital Research Global Investors ,Norges Bank ,Northern Trust Corp ,Citigroup ,Wellington Management Group ,Homestead Advisers Corp ,Free Report ,Advisers Corp ,Research Global Investors ,International Investors ,Management Group ,Trust Corp ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Visit Holdingschannel ,Abbott Laboratories Daily ,